Concentrix (NASDAQ: CNXC) investors approve 3.7M-share increase to 2020 stock plan

Rhea-AI Filing Summary

Concentrix Corporation reported results of its 2026 annual stockholder meeting. Stockholders approved an amendment to the Concentrix Corporation Amended and Restated 2020 Stock Incentive Plan to increase the number of shares available for issuance thereunder by 3,700,000 shares.

They also elected nine directors for terms expiring at the 2027 annual meeting and ratified Ernst & Young LLP as independent registered public accounting firm for fiscal year 2026. In an advisory vote, stockholders approved the compensation of the company’s named executive officers.

8-K Event Classification

3 items: 5.02, 5.07, 9.01

3 items

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers Governance

Key personnel changes including departures, elections, or appointments of directors and executive officers.

Item 5.07 Submission of Matters to a Vote of Security Holders Governance

Results of a shareholder vote on proposals at an annual or special meeting.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, and exhibit attachments filed with this report.

Understanding 8-K Material Events →

0001803599FALSE00018035992026-03-252026-03-25

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of Earliest Event Reported): March 25, 2026

CONCENTRIX CORPORATION

(Exact name of registrant as specified in its charter)

Delaware			001-39494			27-1605762
(State or Other Jurisdiction of Incorporation)			(Commission File Number)			(I.R.S. Employer Identification Number)

39899 Balentine Drive, Suite 235, Newark, California						94560
(Address of principal executive offices)						(Zip Code)

(800) 747-0583

(Registrant’s telephone number, including area code)

N/A

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐			Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐			Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐			Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐			Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240-13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class			Trading Symbol(s)			Name of each exchange on which registered
Common Stock, par value $0.0001 per share			CNXC			The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company   ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   ☐

Item 5.02.    Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

As described below in Item 5.07 of this Current Report on Form 8-K, on March 25, 2026, the stockholders of Concentrix Corporation (the “Company”) approved an amendment (the “Amendment”) to the Concentrix Corporation Amended and Restated 2020 Stock Incentive Plan, as amended (the “2020 Plan”), at the Company’s 2026 Annual Meeting of Stockholders (the “Annual Meeting”) to increase the number of shares available for issuance thereunder by 3,700,000 shares. The Amendment was previously approved by the Company’s Board of Directors.

The foregoing summary is qualified in its entirety by reference to the full text of the Amendment, a copy of which is filed as Exhibit 10.1 to this Form 8-K and is incorporated herein by reference.

Item 5.07.     Submission of Matters to a Vote of Security Holders.

On March 25, 2026, the Company held the Annual Meeting for which the Company’s Board of Directors solicited proxies pursuant to Regulation 14A under the Securities Exchange Act of 1934, as amended.

At the Annual Meeting, the Company’s stockholders (1) elected nine directors to serve on the Company’s Board of Directors, (2) ratified the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for fiscal year 2026, (3) approved, on an advisory basis, the compensation of the Company’s named executive officers, and (4) approved an amendment to the 2020 Plan to increase the number of shares available for issuance thereunder.

Set forth below are the final voting results for these proposals, each of which were described in the Company’s definitive proxy statement filed with the Securities and Exchange Commission on February 13, 2026:

1.The election of nine directors to serve on the Company’s Board of Directors for terms expiring at the Company’s 2027 Annual Meeting of Stockholders.

Nominee			For			Withhold			Broker Non-Votes
Christopher Caldwell			51,981,955			331,206			4,290,089
Chih-Kai Cheng			51,618,330			694,831			4,290,089
LaVerne H. Council			51,866,198			446,963			4,290,089
Jennifer Deason			51,875,444			437,717			4,290,089
Kathryn Hayley			51,525,159			788,002			4,290,089
Kathryn Marinello			52,018,925			294,236			4,290,089
Bilge Ogut			52,102,002			211,159			4,290,089
Dennis Polk			52,018,323			294,838			4,290,089
Ann Vezina			51,872,208			440,953			4,290,089

2.The ratification of the appointment of Ernst & Young LLP as the Company’s independent registered accounting firm for fiscal year 2026.

For			Against			Abstain			Broker Non-Votes
56,049,937			453,129			100,184			—

3.The approval, on an advisory basis, of the compensation of the Company’s named executive officers, as described in the Company’s proxy statement.

For			Against			Abstain			Broker Non-Votes
50,867,486			1,372,520			73,155			4,290,089

4.The approval of an amendment to the Concentrix Corporation Amended and Restated 2020 Stock Incentive Plan, as amended, to increase the number of shares available for issuance thereunder.

For			Against			Abstain			Broker Non-Votes
36,462,977			15,803,365			46,819			4,290,089

.

Item 9.01    Financial Statements and Exhibits.

Exhibit No.						Description
10.1						Amendment No. 1 to the Concentrix Corporation Amended and Restated 2020 Stock Incentive Plan, as amended, dated March 25, 2026.
104						Cover Page Interactive Data File (embedded within the Inline XBRL document).

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: March 27, 2026			CONCENTRIX CORPORATION
			By:			/s/ Jane C. Fogarty
						Jane C. Fogarty Executive Vice President, Legal

FAQ

What did Concentrix (CNXC) stockholders approve regarding the 2020 Stock Incentive Plan?

Concentrix stockholders approved an amendment to the 2020 Stock Incentive Plan, increasing shares available for issuance by 3,700,000 shares. This expands the pool used for equity awards to employees, directors, and other eligible participants under the plan.

Which directors were elected at Concentrix’s 2026 annual meeting?

Stockholders elected nine directors to serve until the 2027 annual meeting. Nominees included Christopher Caldwell, Chih-Kai Cheng, LaVerne H. Council, Jennifer Deason, Kathryn Hayley, Kathryn Marinello, Bilge Ogut, Dennis Polk, and Ann Vezina, each receiving a majority of votes cast.

Who is Concentrix’s independent auditor for fiscal year 2026?

Stockholders ratified Ernst & Young LLP as Concentrix’s independent registered public accounting firm for fiscal year 2026. The ratification received 56,049,937 votes for, 453,129 against, and 100,184 abstentions, with no broker non-votes reported on this proposal.

How did Concentrix (CNXC) stockholders vote on executive compensation?

In an advisory vote, stockholders approved Concentrix’s named executive officer compensation, with 50,867,486 votes for, 1,372,520 against, and 73,155 abstentions, along with 4,290,089 broker non-votes. This reflects support for the company’s disclosed pay practices.

What were the vote results on the Concentrix 2020 Plan amendment?

The amendment to increase shares under the 2020 Stock Incentive Plan received 36,462,977 votes for, 15,803,365 against, and 46,819 abstentions, with 4,290,089 broker non-votes. This approval expands the equity pool available for future incentive awards.

When was the Concentrix 2026 annual stockholder meeting held?

Concentrix held its 2026 annual meeting of stockholders on March 25, 2026. At this meeting, stockholders voted on director elections, auditor ratification, advisory approval of executive compensation, and the amendment to the 2020 Stock Incentive Plan increasing available shares.

Filing Exhibits & Attachments

4 documents

Agreements & Contracts

• EX-10.1 EX-10.1 7.2 KB

Other Documents

• EX-101 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 1.7 KB
• EX-101 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT 22.0 KB
• EX-101 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT 12.7 KB